Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal Cancer

We tested the prognostic relevance of metabolic parameters and their relative changes in patients with metastatic colorectal cancer (mCRC) treated with monoclonal antibody and chemotherapy. SUV(max) (standardized uptake volume), SAM (standardized added metabolic activity) and TLG (total lesion glyco...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pathol Oncol Res
Autors principals: Nemeth, Zsuzsanna, Wijker, Wouter, Lengyel, Zsolt, Hitre, Erika, Borbely, Katalin
Format: Artigo
Idioma:Inglês
Publicat: Springer Netherlands 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7772167/
https://ncbi.nlm.nih.gov/pubmed/32661836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12253-020-00865-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars